These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 1296589

  • 1. Which hormone tests for the diagnosis of polycystic ovary syndrome?
    Robinson S, Rodin DA, Deacon A, Wheeler MJ, Clayton RN.
    Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
    [Abstract] [Full Text] [Related]

  • 2. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 3. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S, van der Spuy ZM.
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [Abstract] [Full Text] [Related]

  • 4. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [Abstract] [Full Text] [Related]

  • 5. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC, Cajdler-Łuba A, Salata I, Bieńkiewicz M, Lewiński A.
    Endokrynol Pol; 2011 Oct; 62(2):120-8. PubMed ID: 21528473
    [Abstract] [Full Text] [Related]

  • 6. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M, López N, Noguera JA, Mendiola J, Hernández AI, Corbalán S, Sanchez M, Torres AM.
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Nov; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
    Barth JH, Field HP, Yasmin E, Balen AH.
    Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
    [Abstract] [Full Text] [Related]

  • 12. The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea.
    Turhan NO, Toppare MF, Seçkin NC, Dilmen G.
    Gynecol Obstet Invest; 1999 Mar; 48(3):183-6. PubMed ID: 10545743
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O, Yalcinoglu AI, Kafkasli A, Burak F, Ozekici U.
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?
    Szydlarska D, Grzesiuk W, Trybuch A, Kondracka A, Kowalik I, Bar-Andziak E.
    Endokrynol Pol; 2012 Jun; 63(5):356-61. PubMed ID: 23115068
    [Abstract] [Full Text] [Related]

  • 15. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.
    Loverro G, Vicino M, Lorusso F, Vimercati A, Greco P, Selvaggi L.
    Gynecol Endocrinol; 2001 Apr; 15(2):142-9. PubMed ID: 11379011
    [Abstract] [Full Text] [Related]

  • 16. Serum total renin is elevated in women with polycystic ovarian syndrome.
    Jaatinen TA, Matinlauri I, Anttila L, Koskinen P, Erkkola R, Irjala K.
    Fertil Steril; 1995 May; 63(5):1000-4. PubMed ID: 7720907
    [Abstract] [Full Text] [Related]

  • 17. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
    Sanke S, Chander R, Jain A, Garg T, Yadav P.
    JAMA Dermatol; 2016 Sep 01; 152(9):986-91. PubMed ID: 27304785
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS).
    Lenarcik A, Bidzińska-Speichert B, Tworowska-Bardzińska U, Krępuła K.
    Endokrynol Pol; 2011 Sep 01; 62(2):129-33. PubMed ID: 21528474
    [Abstract] [Full Text] [Related]

  • 20. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.
    Uncu G, Sözer MC, Develioğlu O, Cengiz C.
    Gynecol Endocrinol; 2002 Dec 01; 16(6):447-52. PubMed ID: 12626031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.